RITROVA THERAPEUTICS Trademark

Trademark Overview


On Wednesday, October 20, 2021, a trademark application was filed for RITROVA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the RITROVA THERAPEUTICS trademark a serial number of 97084529. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Tuesday, August 20, 2024. This trademark is owned by Ritrova Therapeutics Inc.. The RITROVA THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment, prognosis, and diagnosis of neurological, neurodegenerative, neurodevelopmental, psychiatric, and central nervous system diseases and disorders

Biopharmaceutical research and development services in the field of neurological, neurodegenerative, neurodevelopmental, psychiatric, and central nervous system diseases and disorders; research and development services in the field of pharmaceuticals and treatments for neurological, neurodegenerative, neurodevelopmental, psychiatric, and central nervous system disorders and diseases
ritrova therapeutics

General Information


Serial Number97084529
Word MarkRITROVA THERAPEUTICS
Filing DateWednesday, October 20, 2021
Status731 - SECOND EXTENSION - GRANTED
Status DateTuesday, August 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 8, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment, prognosis, and diagnosis of neurological, neurodegenerative, neurodevelopmental, psychiatric, and central nervous system diseases and disorders
Translation of Words in MarkThe English translation of "RITROVA" in the mark is "find again".
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesBiopharmaceutical research and development services in the field of neurological, neurodegenerative, neurodevelopmental, psychiatric, and central nervous system diseases and disorders; research and development services in the field of pharmaceuticals and treatments for neurological, neurodegenerative, neurodevelopmental, psychiatric, and central nervous system disorders and diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, November 7, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, November 7, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRitrova Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10001

Party NameRitrova Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10001

Trademark Events


Event DateEvent Description
Saturday, October 23, 2021NEW APPLICATION ENTERED
Sunday, November 7, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 26, 2022ASSIGNED TO EXAMINER
Tuesday, July 26, 2022NON-FINAL ACTION WRITTEN
Tuesday, July 26, 2022NON-FINAL ACTION E-MAILED
Tuesday, July 26, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 30, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 30, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 30, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 20, 2022NON-FINAL ACTION WRITTEN
Tuesday, September 20, 2022NON-FINAL ACTION E-MAILED
Tuesday, September 20, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 3, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 29, 2023ASSIGNED TO LIE
Thursday, June 29, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 29, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 3, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 19, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 8, 2023PUBLISHED FOR OPPOSITION
Tuesday, August 8, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 3, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, March 28, 2024SOU EXTENSION 1 FILED
Thursday, March 28, 2024SOU EXTENSION 1 GRANTED
Tuesday, August 20, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, August 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 20, 2024SOU EXTENSION 2 FILED
Tuesday, August 20, 2024SOU EXTENSION 2 GRANTED
Friday, March 29, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 28, 2024SOU TEAS EXTENSION RECEIVED